Key result
B-type natriuretic peptide (BtNP) serves as a powerful prognostic predictor for risk stratification in both preoperative and postoperative settings.
Why the study?
Does B-type natriuretic peptide (BtNP) measurement predict perioperative risk?
Does B-type natriuretic peptide (BtNP) measurement predict perioperative risk?
This review highlights the prognostic value of B-type natriuretic peptide for perioperative risk stratification.
BtNP may refine perioperative risk stratification; hypothesis-generating and requires prospective validation before practice change.
Biomarkers are important in diagnosis, assessment of disease severity, risk stratification and therapeutic decision-making. Recent studies strongly suggest that there is a role for B-type natriuretic peptide (BtNP) as a powerful prognostic predictor in both the preoperative and postoperative setting. An understanding is required of the specific statistical methodology that is used to assess the value of biomarkers. The main aim of this paper was to discuss the current role that BtNP plays in perioperative risk prediction.
No takes yet. Share an insight, caveat, or question.
Afshani et al. (2012) conducted a review in Perioperative risk and cardiovascular disease. B-type natriuretic peptide (BtNP) testing was evaluated. B-type natriuretic peptide (BtNP) serves as a powerful prognostic predictor for risk stratification in both preoperative and postoperative settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: